Rapamycin as a preventive intervention for Alzheimer’s disease in APOE4 carriers: targeting brain metabolic and vascular restoration

[Jonas]

Published recently. Small study, positive result. Dose was 1mg per day.
Alzhermer’s trial called by Matt Kaeberlein

Source paper: Rapamycin as a preventive intervention for Alzheimer’s disease in APOE4 carriers: targeting brain metabolic and vascular restoration

From Optispan Podcasts

The Effects of Rapamycin on APOE4 Carriers & Brain Function